Pooler Amy

Sangamo Therapeutics, Inc. · VP

Pooler Amy is listed in filings as VP at Sangamo Therapeutics, Inc.. This profile follows SEC Form 4 activity through Aug 27, 2024, including 2 public disclosures. Recent filings connect the profile to Sangamo Therapeutics, Inc. (SGMO). The current snapshot covers public activity from Aug 27, 2024. Reported amounts are shown as $424 to $605. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

Data sources and methodology

History Trades

CompanyValueActionPriceCurrent Price
Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available.